ArticleDiabetologia2024

Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.

Elise Wreven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.